Determination of Pharmacokinetic Parameters of Amphotericin B in critically ill patients during continuous veno-venous haemodiafiltration.

Intensive Care Unit, The Adelaide and Meath Hospital Incorporating the National Children's Hospital0 个研究点目标入组 40 人开始时间: 2009年5月13日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•All patients admitted to the ICU and who are in receipt of Abelcet or Ambisome as part of their ICU treatment.
•Patients over 18 years old
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Patient under 18 years old, patient/relative refusal, analyst (research investigator) refusal on the basis of patient carrying known serious infectious disease e.g. Hepatitis B or HIV.
•Children under 16
•Adults with learning disabilities
•Adults who have a terminal illness
•Those who could be considered to be vulnerable or have a particularly dependent
•relationship with the investigator, e.g. medical students
•Women of child bearing age will be included, all will have a pregnancy test and pregnant women will be excluded

发起方

Intensive Care Unit, The Adelaide and Meath Hospital Incorporating the National Children's Hospital